Payment overview · 2025
General Payments
$35.52
2 reported records · 1 companies
Healthcare provider profile · identity verified
Laura Morton, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · LOUISVILLE, KY · NPI 1619003951
Verified facts
What the public records show
CMS Open Payments records show Laura Morton, M.D. received $35.52 in general payments during 2025 across 2 reported records.
Otsuka America Pharmaceutical, Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | Unresolved — no canonical attribution shown | $35.52 | 100.0% | 2 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $35.52 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| REXULTI Normalized: rexulti |
Drug | Otsuka America Pharmaceutical, Inc. | $35.52 | 2 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Eliquis | Apixaban | 680 | 77 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 556 | 63 |
| Atorvastatin Calcium | Atorvastatin Calcium | 501 | 89 |
| Levothyroxine Sodium | Levothyroxine Sodium | 453 | 89 |
| Pantoprazole Sodium | Pantoprazole Sodium | 367 | 76 |
| Furosemide | Furosemide | 321 | 82 |
| Potassium Chloride | Potassium Chloride | 321 | 73 |
| Metoprolol Succinate | Metoprolol Succinate | 310 | 61 |
| Amlodipine Besylate | Amlodipine Besylate | 291 | 58 |
| Memantine Hcl | Memantine Hcl | 260 | 44 |
| Metoprolol Tartrate | Metoprolol Tartrate | 248 | 50 |
| Losartan Potassium | Losartan Potassium | 242 | 40 |
| Mirtazapine | Mirtazapine | 227 | 52 |
| Trazodone Hcl | Trazodone Hcl | 211 | 39 |
| Donepezil Hcl | Donepezil Hcl | 204 | 41 |
| Sertraline Hcl | Sertraline Hcl | 192 | 46 |
| Clopidogrel | Clopidogrel Bisulfate | 189 | 35 |
| Tamsulosin Hcl | Tamsulosin Hcl | 183 | 46 |
| Omeprazole | Omeprazole | 178 | 42 |
| Gabapentin | Gabapentin | 174 | 35 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 158 | 29 |
| Nystatin | Nystatin | 147 | 40 |
| Lisinopril | Lisinopril | 131 | 28 |
| Carvedilol | Carvedilol | 127 | 33 |
| Warfarin Sodium | Warfarin Sodium | 125 | 17 |
| Pravastatin Sodium | Pravastatin Sodium | 124 | 20 |
| Duloxetine Hcl | Duloxetine Hcl | 123 | 18 |
| Divalproex Sodium | Divalproex Sodium | 120 | 21 |
| Fluticasone Propionate | Fluticasone Propionate | 116 | 42 |
| Diclofenac Sodium | Diclofenac Sodium | 112 | 29 |
| Levetiracetam | Levetiracetam | 106 | 14 |
| Clonazepam | Clonazepam | 104 | 14 |
| Escitalopram Oxalate | Escitalopram Oxalate | 103 | 20 |
| Buspirone Hcl | Buspirone Hcl | 93 | 23 |
| Montelukast Sodium | Montelukast Sodium | 89 | 18 |
| Fluoxetine Hcl | Fluoxetine Hcl | 86 | 16 |
| Lorazepam | Lorazepam | 85 | 25 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 84 | 11 |
| Finasteride | Finasteride | 83 | 16 |
| Allopurinol | Allopurinol | 82 | 16 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 81 | 12 |
| Famotidine | Famotidine | 79 | 20 |
| Ondansetron Hcl | Ondansetron Hcl | 78 | 29 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 75 | 16 |
| Quetiapine Fumarate | Quetiapine Fumarate | 69 | 17 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 66 | 20 |
| Amiodarone Hcl | Amiodarone Hcl | 65 | 11 |
| Xarelto | Rivaroxaban | 63 | 11 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 62 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 62 | suppressed |
| Cephalexin | Cephalexin | 61 | 30 |
| Bumetanide | Bumetanide | 60 | 14 |
| Metformin Hcl | Metformin Hcl | 55 | 15 |
| Tradjenta | Linagliptin | 55 | suppressed |
| Atenolol | Atenolol | 54 | suppressed |
| Digoxin | Digoxin | 52 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 51 | 11 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 50 | 11 |
| Hydralazine Hcl | Hydralazine Hcl | 49 | 18 |
| Ondansetron Odt | Ondansetron | 49 | 33 |
| Oxycodone Hcl | Oxycodone Hcl | 49 | 14 |
| Prednisone | Prednisone | 49 | 18 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 45 | suppressed |
| Clotrimazole | Clotrimazole | 45 | suppressed |
| Nifedipine Er | Nifedipine | 45 | suppressed |
| Baclofen | Baclofen | 44 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 43 | suppressed |
| Latanoprost | Latanoprost | 43 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 42 | 17 |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 42 | suppressed |
| Lidocaine | Lidocaine | 42 | suppressed |
| Torsemide | Torsemide | 42 | 12 |
| Tramadol Hcl | Tramadol Hcl | 41 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 40 | suppressed |
| Lacosamide | Lacosamide | 40 | suppressed |
| Pregabalin | Pregabalin | 40 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 39 | 24 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 39 | suppressed |
| Bupropion Xl | Bupropion Hcl | 38 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 38 | 12 |
| Ezetimibe | Ezetimibe | 38 | suppressed |
| Risperidone | Risperidone | 35 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 34 | 12 |
| Vilazodone Hcl | Vilazodone Hcl | 34 | suppressed |
| Myrbetriq | Mirabegron | 33 | suppressed |
| Rivastigmine | Rivastigmine | 33 | suppressed |
| Hydrochlorothiazide | Hydrochlorothiazide | 32 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 31 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 31 | 13 |
| Novofine Autocover | Pen Needle, Diabetic, Safety | 31 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 31 | suppressed |
| Betamethasone Dipropionate | Betamethasone Dipropionate | 30 | suppressed |
| Simvastatin | Simvastatin | 30 | suppressed |
| Lactulose | Lactulose | 29 | suppressed |
| Lansoprazole | Lansoprazole | 29 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 29 | suppressed |
| Anastrozole | Anastrozole | 28 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 28 | 19 |
| Farxiga | Dapagliflozin Propanediol | 28 | suppressed |
| Olanzapine | Olanzapine | 28 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 28 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 28 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 27 | suppressed |
| Calcitriol | Calcitriol | 27 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 27 | 17 |
| Midodrine Hcl | Midodrine Hcl | 27 | suppressed |
| Spironolactone | Spironolactone | 27 | 11 |
| Jardiance | Empagliflozin | 26 | suppressed |
| Methotrexate | Methotrexate Sodium | 26 | suppressed |
| Novolog Flexpen | Insulin Aspart | 26 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 25 | suppressed |
| Fluvoxamine Maleate | Fluvoxamine Maleate | 25 | suppressed |
| Loperamide | Loperamide Hcl | 25 | 12 |
| Morphine Sulfate Er | Morphine Sulfate | 25 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 25 | 13 |
| Valsartan | Valsartan | 25 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 24 | suppressed |
| Alprazolam | Alprazolam | 23 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 23 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 23 | suppressed |
| Topiramate | Topiramate | 23 | suppressed |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 22 | 22 |
| Mupirocin | Mupirocin | 22 | 15 |
| Rivastigmine | Rivastigmine Tartrate | 22 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 22 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 22 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 21 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 21 | suppressed |
| Levofloxacin | Levofloxacin | 21 | 13 |
| Namzaric | Memantine Hcl/Donepezil Hcl | 21 | suppressed |
| Galantamine Er | Galantamine Hbr | 20 | suppressed |
| Metolazone | Metolazone | 20 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 20 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 19 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 19 | suppressed |
| Vascepa | Icosapent Ethyl | 19 | suppressed |
| Acetylcysteine | Acetylcysteine | 18 | suppressed |
| Clomipramine Hcl | Clomipramine Hcl | 18 | suppressed |
| Timolol Maleate | Timolol Maleate | 18 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 17 | suppressed |
| Travoprost | Travoprost | 17 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 16 | 11 |
| Clonidine | Clonidine | 16 | suppressed |
| Januvia | Sitagliptin Phosphate | 16 | suppressed |
| Azithromycin | Azithromycin | 15 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 15 | suppressed |
| Glycopyrrolate | Glycopyrrolate | 15 | suppressed |
| Linzess | Linaclotide | 15 | suppressed |
| Silver Sulfadiazine | Silver Sulfadiazine | 15 | suppressed |
| Sotalol | Sotalol Hcl | 15 | suppressed |
| Toprol Xl | Metoprolol Succinate | 15 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 15 | suppressed |
| Ursodiol | Ursodiol | 15 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 14 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 14 | suppressed |
| Estradiol | Estradiol | 14 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 14 | suppressed |
| Lamotrigine | Lamotrigine | 14 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 14 | suppressed |
| Nyamyc | Nystatin | 14 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 14 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 13 | suppressed |
| Chlorthalidone | Chlorthalidone | 13 | suppressed |
| Dapsone | Dapsone | 13 | suppressed |
| Humulin R | Insulin Regular, Human | 13 | suppressed |
| Hydroxyurea | Hydroxyurea | 13 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 13 | suppressed |
| Irbesartan | Irbesartan | 13 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl | 13 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 13 | suppressed |
| Phenobarbital | Phenobarbital | 13 | suppressed |
| Trulicity | Dulaglutide | 13 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 12 | suppressed |
| Aripiprazole | Aripiprazole | 12 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 12 | suppressed |
| Enoxaparin Sodium | Enoxaparin Sodium | 12 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 12 | suppressed |
| Multaq | Dronedarone Hcl | 12 | suppressed |
| Sucralfate | Sucralfate | 12 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 11 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 11 | suppressed |
| Cefdinir | Cefdinir | 11 | suppressed |
| Cyclosporine | Cyclosporine | 11 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 11 | suppressed |
| Fluphenazine Hcl | Fluphenazine Hcl | 11 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 11 | suppressed |
| Oxycontin | Oxycodone Hcl | 11 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 11 | suppressed |
| Premarin | Estrogens, Conjugated | 11 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 11 | suppressed |
| Zonisamide | Zonisamide | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $35.52 · 2 records | Otsuka America Pharmaceutical, Inc. | REXULTI | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error